PURPOSE: To evaluate sex as a possible prognostic factor in bladder cancer patients treated with transurethral resection (TURBT) and radio- (RT) or radiochemotherapy (RCT). METHODS: Kaplan-Meier analyses and multiple Cox proportional hazards regression analyses were performed to analyze sex as a possible prognostic factor on the overall (OS) and cancer-specific (CSS) survival of 386 male and 105 female patients who underwent TURBT and RCT or RT with curative intent between 1982 and 2007. RESULTS: After a follow-up of 5 years, female sex demonstrated a hazard ratio (HR) of 1.79 (95 % CI 1.24-2.57) for OS; for CSS, the HR was 2.4 (95 % CI 1.52-3.80). Sex was an adverse prognosticator of both OS and CSS independent from age at diagnosis, cT stage, grading, concurrent cis, LVI, focality, therapy response, resection status and therapy mode. Kaplan-Meier analysis showed significantly reduced OS of women compared with men, with a median survival of 2.3 years for female patients and 5.1 years for male patients (p = 0.045, log-rank test). The estimated median CSS was 7.1 years for female patients and 12.7 years for male patients (p = 0.11, log-rank test). CONCLUSIONS: Female sex is an independent prognostic factor for reduced OS and CSS in bladder cancer patients treated by TURBT and RT or RCT. These data are in agreement with those reported for OS after radical cystectomy in muscle-invasive bladder cancers. Therefore, further studies are strongly warranted to obtain more information about molecular differences regarding sex-specific carcinogenesis in bladder cancer and about possible therapeutic considerations.
PURPOSE: To evaluate sex as a possible prognostic factor in bladder cancerpatients treated with transurethral resection (TURBT) and radio- (RT) or radiochemotherapy (RCT). METHODS: Kaplan-Meier analyses and multiple Cox proportional hazards regression analyses were performed to analyze sex as a possible prognostic factor on the overall (OS) and cancer-specific (CSS) survival of 386 male and 105 female patients who underwent TURBT and RCT or RT with curative intent between 1982 and 2007. RESULTS: After a follow-up of 5 years, female sex demonstrated a hazard ratio (HR) of 1.79 (95 % CI 1.24-2.57) for OS; for CSS, the HR was 2.4 (95 % CI 1.52-3.80). Sex was an adverse prognosticator of both OS and CSS independent from age at diagnosis, cT stage, grading, concurrent cis, LVI, focality, therapy response, resection status and therapy mode. Kaplan-Meier analysis showed significantly reduced OS of women compared with men, with a median survival of 2.3 years for female patients and 5.1 years for male patients (p = 0.045, log-rank test). The estimated median CSS was 7.1 years for female patients and 12.7 years for male patients (p = 0.11, log-rank test). CONCLUSIONS: Female sex is an independent prognostic factor for reduced OS and CSS in bladder cancerpatients treated by TURBT and RT or RCT. These data are in agreement with those reported for OS after radical cystectomy in muscle-invasive bladder cancers. Therefore, further studies are strongly warranted to obtain more information about molecular differences regarding sex-specific carcinogenesis in bladder cancer and about possible therapeutic considerations.
Authors: Matthias May; Christian Stief; Sabine Brookman-May; Wolfgang Otto; Christian Gilfrich; Jan Roigas; Mario Zacharias; Wolf F Wieland; Hans-Martin Fritsche; Ferdinand Hofstädter; Maximilian Burger Journal: World J Urol Date: 2011-10-09 Impact factor: 4.226
Authors: Matthias May; Patrick J Bastian; Sabine Brookman-May; Hans-Martin Fritsche; Derya Tilki; Wolfgang Otto; Christian Bolenz; Christian Gilfrich; Lutz Trojan; Edwin Herrmann; Rudolf Moritz; Arne Tiemann; Stefan C Müller; Jörg Ellinger; Alexander Buchner; Christian G Stief; Wolf F Wieland; Thomas Höfner; Markus Hohenfellner; Axel Haferkamp; Jan Roigas; Mario Zacharias; Philipp Nuhn; Maximilian Burger Journal: Urol Oncol Date: 2011-11-06 Impact factor: 3.498
Authors: Derya Tilki; Robert S Svatek; Pierre I Karakiewicz; Hendrik Isbarn; Oliver Reich; Wassim Kassouf; Yves Fradet; Giacomo Novara; Hans-Martin Fritsche; Patrick J Bastian; Jonathan I Izawa; Christian G Stief; Vincenzo Ficarra; Seth P Lerner; Mark Schoenberg; Colin P Dinney; Eila Skinner; Yair Lotan; Arthur I Sagalowsky; Shahrokh F Shariat Journal: J Urol Date: 2010-01 Impact factor: 7.450
Authors: Leslie K Ballas; Stephanie Navarro; Chunqiao Luo; Croix C Fossum; Albert Farias; Siamak Daneshmand; Susan Groshen Journal: Cancer Med Date: 2021-03-28 Impact factor: 4.452
Authors: Mohd Nasrullah Nik Ab Kadir; Suhaily Mohd Hairon; Najib Majdi Yaacob; Azizah Ab Manan; Nabihah Ali Journal: Int J Environ Res Public Health Date: 2021-05-14 Impact factor: 3.390
Authors: Mohd Nasrullah Nik Ab Kadir; Suhaily Mohd Hairon; Najib Majdi Yaacob; Azizah Ab Manan; Nabihah Ali Journal: Int J Environ Res Public Health Date: 2022-03-04 Impact factor: 3.390